Exploring the landscape of biosimilars, this content delves into the regulatory aspects, interchangeability, formulary management, and future implications of these biologic alternatives. With a focus on the dominance of biologics in the market, comparisons with small molecule drugs, and the complexi

0 views • 40 slides

Explore the world of biosimilars, the complexities of comparing generic and brand drugs, FDA regulations, and the first FDA-approved biosimilar. Learn about biological products, the Biologics Price Competition and Innovation Act, and the challenges in defining potency, purity, and stability in biolo

0 views • 26 slides